1 |
X. Liu and M. Winey, "The MPS1 family of protein kinases", Annu. Rev. Biochem., Vol. 81, pp. 561-585, 2012.
DOI
|
2 |
M. Winey, L. Goetsch, P. Baum, and B. Byers, "MPS1 and MPS2: novel yeast genes defining distinct steps of spindle pole body duplication", The Journal of Cell Biology, Vol.114, pp. 745-754, 1991.
DOI
|
3 |
A. M. Wengner, G. Siemeister, M. Koppitz, V. Schulze, D. Kosemund, U. Klar, D. Stoeckigt, R. Neuhaus, P. Lienau, B. Bader, S. Prechtl, M. Raschke, A.-L. Frisk, O. von Ahsen, M. Michels, B. Kreft, F. von Nussbaum, M. Brands, D. Mumberg, and K. Ziegelbauer, "Novel Mps1 kinase inhibitors with potent antitumor activity", Mol. Cancer Ther., Vol. 15, pp. 583-592, 2016.
DOI
|
4 |
A. R. Schutz and M. Winey, "New alleles of the yeast MPS1 gene reveal multiple requirements in spindle pole body duplication", Mol. Biol. Cell, Vol. 9, pp. 759-774, 1998.
DOI
|
5 |
A. Abrieu, L. Magnaghi-Jaulin, J. A. Kahana, M. Peter, A. Castro, S. Vigneron, T. Lorca, D. W. Cleveland, and J.-C. Labbe, "Mps1 is a kinetochore-associated kinase essential for the vertebrate mitoticCheckpoint", Cell, Vol. 106, pp. 83-93, 2001.
DOI
|
6 |
V. M. Stucke, H. H. W. Sillje, L. Arnaud, and E. A. Nigg, "Human Mps1 kinase is required for the spindle assembly checkpoint but not for centrosome duplication", EMBO J., Vol. 21, pp. 1723-1732, 2002.
DOI
|
7 |
H. A. Fisk, C. P Mattison, and M. Winey, "Human Mps1 protein kinase is required for centrosome duplication and normal mitotic progression", P. Natl. Acad. Sci, U.S.A., Vol. 100, pp. 14875-14880, 2003.
DOI
|
8 |
K. Nihira, N. Taira, Y. Miki, and K. Yoshida, "TTK/Mps1 controls nuclear targeting of c-Abl by 14-3-3-coupled phosphorylation in response to oxidative stress", Oncogene, Vol. 27, pp. 7285-7295, 2008.
DOI
|
9 |
J. Daniel, J. Coulter, J. H. Woo, K. Wilsbach, and E. Gabrielson, "High levels of the Mps1 checkpoint protein are protective of aneuploidy in breast cancer cells", P. Natl. Acad. Sci. U.S.A., Vol. 108, 5384-5389, 2011.
DOI
|
10 |
M. T. Landi, T. Dracheva, M. Rotunno, J. D. Figueroa, H. Liu, A. Dasgupta, F. E. Mann, J. Fukuoka, M. Hames, A. W. Bergen, S. E. Murphy, P. Yang, A. C. Pesatori, D. Consonni, P. A. Bertazzi, S. Wacholder, J. H. Shih, N. E. Caporaso, and J. Jen, "Gene expression signature of cigarette smoking and its role in lung adenocarcinoma development and survival", Plos One, Vol. 3, pp. e1651, 2008.
DOI
|
11 |
G. Salvatore, T. C. Nappi, P. Salerno, Y. Jiang, C. Garbi, C. Ugolini, P. Miccoli, F. Basolo, M. D. Castellone, A. M. Cirafici, R. M. Melillo, A. Fusco, M. L. Bittner, and M. Santoro, "A cell proliferation and chromosomal instability signature in anaplastic thyroid Carcinoma", Cancer Res., Vol. 67, pp. 10148-10158, 2007.
DOI
|
12 |
P. K. Balasubramanian, A. Balupuri, and S. J. Cho, "A CoMFA study of phenoxypyridine-based JNK3 inhibitors using various partial charge schemes", J. Chosun Natural Sci., Vol. 7, pp. 45-49, 2014.
DOI
|
13 |
B. Yuan, Y. Xu, J.-H. Woo, Y. Wang, Y. K. Bae, D.-S. Yoon, R. P. Wersto, E. Tully, K. Wilsbach, and E. Gabrielson, "Increased expression of mitotic checkpoint genes in breast cancer cells with chromosomal instability", Clin. Cancer Res., Vol. 12, pp. 405-410, 2006.
DOI
|
14 |
E Manchado, M Guillamot, and M. Malumbres, "Killing cells by targeting mitosis", Cell Death Differ., Vol. 19, pp. 369-377, 2012.
DOI
|
15 |
K.-I. Kusakabe et al., "Discovery of imidazo[1,2-b]pyridazine derivatives: selective and orally available Mps1 (TTK) kinase inhibitors exhibiting remarkable antiproliferative activity", J. Med. Chem., Vol. 58, 1760-1775, 2015.
DOI
|
16 |
P. K. Balasubramanian and S. J. Cho, "HQSAR analysis on novel series of 1-(4-phenylpiperazin-1-yl-2-(1H-pyrazol-1-yl) ethanone derivatives targeting CCR1", J. Chosun Natural Sci., Vol. 6, pp. 163-169, 2013.
DOI
|
17 |
A. Balupuri and S. J.Cho, "Exploration of the binding mode of indole derivatives as potent HIV-1 inhibitors using molecular docking simulations", J. Chosun Natural Sci., Vol. 6, pp. 138-142, 2013.
DOI
|
18 |
P. K. Balasubramanian, A. Balupuri, and S. J. Cho, "3D QSAR study on pyrrolopyrimidines-based derivatives as LIM2 kinase inhibitors", J. Chosun Natural Sci., Vol. 8, pp. 285-292, 2015.
DOI
|
19 |
S. J. Cho, "The importance of halogen bonding: A tutorial", J. Chosun Natural Sci., Vol. 5, pp. 195-197, 2012.
DOI
|
20 |
SYBYLx2.1, Tripos International, 1699 South Hanley Road, St. Louis, Missouri, 63144, USA.
|
21 |
R. D. Cramer, D. E. Patterson, and J. D. Bunce, "Comparative molecular field analysis (CoMFA). 1. Effect of shape on binding of steroids to carrier proteins", J. Am. Chem. Soc., Vol. 110, pp. 5959-5967,1988.
DOI
|